Prognostic role of the lymphocyte‐to‐monocyte ratio for clinical outcomes of patients with progressive radioiodine‐refractory differentiated thyroid carcinoma treated by sorafenib
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic role of the lymphocyte‐to‐monocyte ratio for clinical outcomes of patients with progressive radioiodine‐refractory differentiated thyroid carcinoma treated by sorafenib
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume 92, Issue 1, Pages 71-76
Publisher
Wiley
Online
2019-10-30
DOI
10.1111/cen.14120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers
- (2019) Jae Won Cho et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Low lymphocyte-to-monocyte ratios are associated with poor overall survival in anaplastic thyroid carcinoma patients
- (2019) Jonghwa Ahn et al. THYROID
- Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis
- (2018) Ru-jin Hu et al. CLINICA CHIMICA ACTA
- Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis
- (2018) Ru-jin Hu et al. CLINICA CHIMICA ACTA
- Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
- (2018) Mijin Kim et al. THYROID
- Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
- (2018) Zhenfeng Zhu et al. OncoTargets and Therapy
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
- (2015) Tomohiro F. Nishijima et al. CANCER TREATMENT REVIEWS
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection
- (2015) Ze-Xiao Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8
- (2014) Weiyuan Fang et al. CARCINOGENESIS
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma
- (2014) Xiaolei Wei et al. LEUKEMIA RESEARCH
- The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories
- (2013) Yan-gao Man et al. Journal of Cancer
- Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
- (2012) Roniel Cabrera et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma
- (2012) Lucas L. Cunha et al. CLINICAL ENDOCRINOLOGY
- Density of Tumor-Associated Macrophages Correlates with Lymph Node Metastasis in Papillary Thyroid Carcinoma
- (2012) Wei Qing et al. THYROID
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma
- (2011) L. F. Porrata et al. HAEMATOLOGICA
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma
- (2009) Eui Young Kim et al. CLINICAL ENDOCRINOLOGY
- Thyroid cancer and inflammation
- (2009) Valentina Guarino et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
- (2009) R. Houben et al. MOLECULAR CANCER THERAPEUTICS
- Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
- (2008) M. Ryder et al. ENDOCRINE-RELATED CANCER
- Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation
- (2008) W Zhao et al. LEUKEMIA
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now